Correlated and high-dimensional data arise frequently in health sciences research, especially in cancer research. Correlated data arise in longitudinal studies and familial studies, while high-dimensional data have emerged in recent years as a consequence of the rapid advance of genomic and proteomic research. We propose in this application to develop nonparametric and semiparametric regression methods for clustered/longitudinal data and high-dimensional genomic and proteomic data. Specifically, we propose to develop (1) the kernel (spline) profile EM method for generalized semiparametric mixed models for clustered/longitudinal data;(2) nonparametric and semiparametric regression models for longitudinal data with dropouts;(3) the mixed model kernel machine method for generalized semiparametric regression models and semiparametric Cox models for the analysis of gene expression pathways and tag single nucleotide polymorphisms (SNPs) within a candidate gene, and the sparse kernel machine (SKM) method for selecting genes and tag SNPs from a large pool of genes or tag SNPs;(4) the joint modeling method using functional wavelet models and generalized semiparametric models for mass spectrometry proteomic data and disease outcomes. Asymptotic properties of the proposed methods will be investigated and simulation studies will be conducted to evaluate their finite sample performance. Efficient numerical algorithms and user-friendly statistical software will be developed, with the goal of disseminating these models and methods to health sciences researchers. In collaboration with biomedical investigators, we will apply the proposed models and methods to several motivating data sets on cancer research and other fields of research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37CA076404-17
Application #
8461913
Study Section
Special Emphasis Panel (NSS)
Program Officer
Dunn, Michelle C
Project Start
1997-12-15
Project End
2016-03-31
Budget Start
2013-04-01
Budget End
2014-03-31
Support Year
17
Fiscal Year
2013
Total Cost
$289,844
Indirect Cost
$110,374
Name
Harvard University
Department
Biostatistics & Other Math Sci
Type
Schools of Public Health
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02115
Sofer, Tamar; Schifano, Elizabeth D; Christiani, David C et al. (2017) Weighted pseudolikelihood for SNP set analysis with multiple secondary outcomes in case-control genetic association studies. Biometrics 73:1210-1220
Chen, Jun; Behnam, Ehsan; Huang, Jinyan et al. (2017) Fast and robust adjustment of cell mixtures in epigenome-wide association studies with SmartSVA. BMC Genomics 18:413
Barnett, Ian; Mukherjee, Rajarshi; Lin, Xihong (2017) The Generalized Higher Criticism for Testing SNP-Set Effects in Genetic Association Studies. J Am Stat Assoc 112:64-76
Chen, Jun; Just, Allan C; Schwartz, Joel et al. (2016) CpGFilter: model-based CpG probe filtering with replicates for epigenome-wide association studies. Bioinformatics 32:469-71
Chen, Han; Wang, Chaolong; Conomos, Matthew P et al. (2016) Control for Population Structure and Relatedness for Binary Traits in Genetic Association Studies via Logistic Mixed Models. Am J Hum Genet 98:653-66
Lin, Xinyi; Lee, Seunggeun; Wu, Michael C et al. (2016) Test for rare variants by environment interactions in sequencing association studies. Biometrics 72:156-64
Yung, Godwin; Lin, Xihong (2016) Validity of using ad hoc methods to analyze secondary traits in case-control association studies. Genet Epidemiol 40:732-743
Lee, Seunggeung; Abecasis, Gonçalo R; Boehnke, Michael et al. (2014) Rare-variant association analysis: study designs and statistical tests. Am J Hum Genet 95:5-23
Liao, Shu-Yi; Lin, Xihong; Christiani, David C (2014) Genome-wide association and network analysis of lung function in the Framingham Heart Study. Genet Epidemiol 38:572-8
Cao, Yin; Lindström, Sara; Schumacher, Fredrick et al. (2014) Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survival. J Natl Cancer Inst 106:dju085

Showing the most recent 10 out of 67 publications